Noxopharm Ltd Financial Flexibility Index
Noxopharm Ltd financial flexibility index. Noxopharm Ltd (NOX) has a Financial Flexibility Index of -0.46x as of December 2025. Free cash flow of AU$-2.71 Million (operating CF AU$-2.71 Million minus capex AU$0.00) represents 0% of total liabilities (AU$5.88 Million). See NOX FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Noxopharm Ltd (2016–2025)
Financial flexibility index of Noxopharm Ltd from 2016 to 2025. Historical Financial Flexibility Index trend for Noxopharm Ltd across 10 annual periods. Check NOX cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Noxopharm Ltd Financial Flexibility Index by Year (2016–2025)
Noxopharm Ltd financial flexibility index by year from 2016 to 2025. Year-by-year free cash flow to debt coverage for Noxopharm Ltd. For the full cash flow conversion analysis, see cash efficiency ratio of Noxopharm Ltd.
| Year | Flexibility Index | Free Cash Flow (AUD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.50x | AU$-5.82 Million | AU$-5.82 Million | AU$3.89 Million | ▼ -181.9% |
| 2024 | -0.53x | AU$-684.31K | AU$-684.31K | AU$1.29 Million | ▲ +94.9% |
| 2023 | -10.37x | AU$-10.95 Million | AU$-10.95 Million | AU$1.06 Million | ▼ -87.0% |
| 2022 | -5.55x | AU$-13.73 Million | AU$-13.73 Million | AU$2.48 Million | ▼ -343.6% |
| 2021 | -1.25x | AU$-8.85 Million | AU$-8.85 Million | AU$7.08 Million | ▲ +19.2% |
| 2020 | -1.55x | AU$-11.13 Million | AU$-11.14 Million | AU$7.19 Million | ▲ +8.9% |
| 2019 | -1.70x | AU$-9.77 Million | AU$-9.78 Million | AU$5.75 Million | ▲ +14.7% |
| 2018 | -1.99x | AU$-8.76 Million | AU$-9.08 Million | AU$4.40 Million | ▲ +74.7% |
| 2017 | -7.86x | AU$-2.84 Million | AU$-2.92 Million | AU$361.04K | ▼ -288.5% |
| 2016 | -2.02x | AU$-529.79K | AU$-549.72K | AU$261.72K | — |